Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 62 Results

Title
Intervention Indication Therapeutic Area Year Actions
Abatacept for treating idiopathic inflammatory myopathies Abatacept (Orencia) Idiopathic inflammatory myopathies Immunology , Musculoskeletal System 2022 View  |  Download
Abatacept with a calcineurin inhibitor and methotrexate for prophylaxis of acute graft versus host disease Abatacept (Orencia) Graft versus host disease (GvHD) Immunology 2022 View  |  Download
Amivantamab with chemotherapy for previously untreated advanced EGFR exon 20 insertion mutations positive non-small cell lung cancer Amivantamab (JNJ-6372; JNJ-61186372) , Chemotherapy Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
ASTX727 for acute myeloid leukaemia ASTX727 Acute lymphoblastic leukaemia (ALL) Haematological Cancer and Lymphomas 2022 View  |  Download
Atezolizumab adjuvant therapy for treating renal cell carcinoma in people at high risk of developing metastasis following nephrectomy Atezolizumab (Tecentriq; MPDL3280A) Renal cell carcinoma (RCC) Renal Cancer 2022 View  |  Download
Atogepant for prevention of migraine Atogepant (AGN-241689; MK-8031) Migraine Neurology 2022 View  |  Download
Baricitinib for treating atopic dermatitis in children and adolescents Baricitinib (LY3009104; Olumiant) Atopic dermatitis Dermatology 2022 View  |  Download
Bempegaldesleukin in combination with nivolumab for previously untreated unresectable or metastatic melanoma Bempegaldesleukin (NKTR-214; BMS-986321; NEKTAR) , Nivolumab (Opdivo; BMS-936558; ONO-4538) Melanoma Skin Cancer 2022 View  |  Download
Benralizumab for treating eosinophilic oesophagitis in people aged 12-65 years Benralizumab (Fasenra; MEDI563) Eosinophilic oesophagitis Gastroenterology 2022 View  |  Download
Bimekizumab for Hidradenitis Suppurativa Bimekizumab (UCB4940) Hidradenitis suppurativa (HS) Dermatology 2022 View  |  Download
1 2 3 6 7
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications